Anya Biopharm Inc. (TPEX:7776)
Taiwan · Delayed Price · Currency is TWD 26.20
-2.45 (-8.55%)
At close: Nov 6, 2026
Anya Biopharm Revenue
Anya Biopharm had revenue of 728.00K TWD in the half year ending June 30, 2026, with 4.00% growth. This brings the company's total for the last twelve months to 13.06M, down -47.41% year-over-year. In the year 2025, Anya Biopharm had annual revenue of 16.27M, down -24.66%. That makes Anya Biopharm the 44,787th largest company in the world by revenue and 2,181st in Taiwan.
Revenue (ttm)
13.06M
Revenue Growth
-47.41%
P/S Ratio
98.50
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.29B
Revenue by Geography
- Asia 14.85M 91.3%
- Europe 849.00K 5.2%
- Taiwan 571.00K 3.5%
Fiscal year ended Dec 31, 2025 See the full Anya Biopharm breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.27M | -5.33M | -24.66% |
| Dec 31, 2024 | 21.60M | 19.28M | 831.26% |
| Dec 31, 2023 | 2.32M | -177.00K | -7.09% |
| Dec 31, 2022 | 2.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.